KTC
GWPH

Kistler-Tiffany Companies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kistler-Tiffany Companies’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-44
Closed -$4K – 726
2016
Q2 		$4K Buy
+44
New +$3.7K ﹤0.01% 497

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kistler-Tiffany Companies's GWPH Position: Q3 2016 in Review

Kistler-Tiffany Companies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2016, closing a stake of 44 shares — an estimated $4K sold.

Kistler-Tiffany Companies first reported a position in GWPH in Q2 2016 and held it in 1 quarter. The position peaked at $4K in Q2 2016. 138 funds tracked by Wall St. Rank hold GWPH as of Q3 2016.

  • Kistler-Tiffany Companies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2016 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 44 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2016, an estimated $4K.
  • Kistler-Tiffany Companies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2016 and held it in 1 quarter.
  • Kistler-Tiffany Companies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4K in Q2 2016.
  • 138 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2016.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2016, filed 8 Nov 2016.